Mad in America

FEBRUARY 13, 2024

Those trapped there due to their emotions, thoughts, and behaviors are controlled by pharmaceutical Americans and their cultish mindset hailing drugs at the expense of everything else. Of course, psychiatrists rarely say the quiet parts out loud; their status as pharmaceutical Americans could come into jeopardy if they did.

Pharmaceuticals 138

Pharmaceuticals Sleep and mental health Construction Legal 138

Mad in America

SEPTEMBER 18, 2024

The pharmaceutical industry has downplayed the risks of withdrawal symptoms following the discontinuation of antidepressant medications. Giovanni Fava posed a controversial question: could antidepressants be worsening the very conditions they were designed to treat?

Pharmaceuticals 145

Pharmaceuticals 145

Mad in America

FEBRUARY 20, 2024

Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. Maelys Touya was an employee of Lundbeck LLC, and Lambros Chrones was an employee of Takeda Pharmaceuticals U.S.A., The study was authored by Judith J. Additionally, Anita H.

Aging and mental health 139

Aging and mental health Pharmaceuticals Insurance Healthcare 139

Mad in America

DECEMBER 2, 2023

Yousaf Raza Illicit Ties with the Pharmaceutical Industry Prescribing more medications than are justified is the number-one crime of which a shamefully large number of psychiatrists are guilty. The answer is simple: it is also the standard that pharmaceutical companies hold us to. This is where the kickbacks come from.

Biopsychosocial model 138

Biopsychosocial model Pharmaceuticals Hospitality Healthcare 138

Mad in America

APRIL 24, 2025

I fear that the American populace has been coercedby pervasive pharmaceutical marketing and academic psychiatrys obfuscations into believing a compelling but dubious tale about the nature of antidepressants.

Neurotransmitters and mental health 108

Neurotransmitters and mental health Trauma and the brain Aging and mental health Pharmaceuticals 108

Psychiatric Times

MARCH 31, 2025

LB Pharmaceuticals presented additional positive data from NOVA1 exploring LB-102 in patients with acutely exacerbated schizophrenia, at the 2025 Annual Congress of the Schizophrenia International Research Society.

Pharmaceuticals 88

Pharmaceuticals 88

Mad in America

MARCH 26, 2025

Third, his journal told of the corrupting influence of pharmaceutical money on the creation of psychiatric diagnoses and drug trials. Whitaker: There are those two funding sources, open access where people have to pay, or journals where they’re basically funded by pharmaceutical advertisements. Fava: Right, and the libraries.

Biopsychosocial model 81

Biopsychosocial model Pharmaceuticals Bipolar disorder Anxiety disorders 81

Mad in America

APRIL 5, 2024

Levine regarding the problem of depression in America. ” Back to Around the Web The post Debunking the Myths About Depression and Antidepressants appeared first on Mad In America.

Pharmaceuticals 90

Pharmaceuticals 90

Mad in America

NOVEMBER 27, 2023

as they uncover the intricate dynamics of the Medical and Pharmaceutical Industry. From The Real Truth About Health : “Join us for an eye-opening discussion with Mary J. Ruwart, Ph.D., Robert Whitaker, and John Abramson, M.D. This discussion provides essential information to protect and promote your health.”

Pharmaceuticals 104

Pharmaceuticals Healthcare 104

Mad in America

DECEMBER 20, 2023

For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Moore: The last couple of questions are related to the pharmaceutical industry. Thank you to all of you who took the time and trouble to send in your questions.

Pharmaceuticals 144

Pharmaceuticals Aging and mental health Biopsychosocial model Hospitality 144

Mad in America

APRIL 15, 2025

It is a reflection of deep systemic issuessocial pressure, medical hierarchy, lack of education around mental healththat collectively push people into silent suffering and pharmaceutical dependence. It is time to ask not only how many people are receiving medication, but why so few are being offered real alternatives.

Aging and mental health 84

Aging and mental health Sleep and mental health Trauma and the brain Insurance 84

Mad in America

JANUARY 15, 2024

One pharmaceutical journal berated some managed care companies for not paying for Viagra for drug-induced sexual dysfunction. However, I doubt that a pharmaceutical company would market Viagra as a treatment for depression; to do so one would have to diagnose depression as caused by an “insufficient blood supply to the genitals”!

Healthcare 98

Healthcare Pharmaceuticals 98

Mad in America

OCTOBER 13, 2023

The pharmaceutical industry set out to change that mindset when they were marketing the SSRIs and SNRIs, with campaigns that told people depression was caused by a chemical imbalance. Prior to the 1990s, people generally thought of depression, in particular, as a reaction to life events.

Pharmaceuticals 134

Pharmaceuticals 134

Mad in America

JANUARY 4, 2025

In our 2015 book Psychiatry Under the Influence , Lisa Cosgrove and I wrote about the STAR*D scandal in depth, as it served as an example of the institutional corruption in psychiatry due to pharmaceutical interests and psychiatrys own guild interests. The 12 STAR*D authors listed a collective total of 151 ties to pharmaceutical companies.

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Mad in America

MARCH 27, 2024

The RCTs were mostly funded by the pharmaceutical industry, and they included abrupt discontinuation of the antipsychotic drug—which causes withdrawal effects that could be mistaken for poor outcomes after discontinuation. The included RCTs have their own biases, which may account for this finding, according to the researchers.

Pharmaceuticals 145

Pharmaceuticals 145

Mad in America

NOVEMBER 6, 2023

Because the FDA requires that pharmaceutical companies submit data on all trials that will be used for regulatory approval, it is possible to examine the data from all the pivotal studies conducted rather than just the ones that end up published.

Pharmaceuticals 127

Pharmaceuticals Hospitality 127

Mad in America

OCTOBER 12, 2024

It seemed then that pharmaceutical companies had discovered scientific, targeted treatments for depression, free of side effects. SSRI antidepressants and other blockbuster psychiatric drugs were released in the late 1980s and early 1990s.

Self-awareness 136

Self-awareness Nonprofits Pharmaceuticals Education 136

Mad in America

MARCH 20, 2025

Doing so would also include allowing them to bear the potential consequences of rejecting assistance, such as legal action and social disapproval, as well as the consequences of requesting assistance, such as the potential harms of pharmaceutical interventions.

Pharmaceuticals 105

Pharmaceuticals Legal Anxiety disorders Healthcare 105

Mad in America

SEPTEMBER 26, 2024

Most of the studies included in the review were not designed to detect withdrawal, they involved people who had used antidepressants for a few weeks or months only and they were mostly funded by pharmaceutical companies which have little interest in conducting a thorough assessment of withdrawal.

Pharmaceuticals 145

Pharmaceuticals 145

Mad in America

DECEMBER 21, 2024

and of course a host of pharmaceutical drugs. At the same time, people with high ACE scores are also more likely to do drug of all kindstobacco, marijuana, alcohol, opiates, mushrooms, etc., They are also more likely to be depressed. Theyre more likely to develop heart and lung diseases, cancers, and other health issues.

Trauma and the brain 141

Trauma and the brain Construction Sleep and mental health Pharmaceuticals 141

Mad in America

MARCH 20, 2024

When medical historians say, “This particular person got an appreciable amount of money from a pharmaceutical company, in this case, Merck and Parke-Davis,” we want to know how much money it is. He wanted his friends to use this drug, he wanted his family members to use this drug. He was also a major user for an extended period.

Genetics and mental health 142

Genetics and mental health Self-awareness Pharmaceuticals Legal 142

Mad in America

FEBRUARY 14, 2024

That suit became the blueprint for the tribal opioid lawsuit that resulted in a $590m settlement in 2022 between the nation’s largest makers and distributors of opioids, including pharmaceutical giant Johnson & Johnson, and the nation’s 574 federally recognized tribes.

Manufacturing 95

Manufacturing Pharmaceuticals 95

Psychiatric Times

APRIL 1, 2025

Vanda Pharmaceuticals has submitted an NDA for approval of Bysanti for the treatment of acute bipolar I disorder and schizophrenia.

Pharmaceuticals 52

Pharmaceuticals 52

Center for Integrative Psychiatry

FEBRUARY 24, 2025

While naturopathic doctors focus on natural therapies, their ability to prescribe pharmaceutical drugs depends on licensing, education, and state regulations. Their approach often includes herbal medicine, acupuncture, dietary counseling, and lifestyle coaching before turning to pharmaceuticals.

Pharmaceuticals 52

Pharmaceuticals Healthcare Insurance Legal 52

Mad in America

FEBRUARY 10, 2024

‘So, it had to convince people that they had an underlying disease and needed to take the drugs for an underlying disease.’” ’” Moncrieff has been instrumental in bringing to light the issues associated with psychiatric drugs and in stating why it’s so important that people know the truth.

Cognitive Behavioral Therapy 144

Cognitive Behavioral Therapy Mental health policy Pharmaceuticals Depression treatment 144

Mad in America

DECEMBER 19, 2024

This chemical imbalance theory, propagated by the psychiatric establishment, is generally considered to be a marketing gimmick by those able to see through the evils of the corporate-driven pharmaceutical industry. Another explanation from psychiatry is that there is a genetic component.

Genetics and mental health 130

Genetics and mental health Pharmaceuticals 130

Reidbord's Reflections

SEPTEMBER 10, 2022

Avanir Pharmaceuticals released Nuedexta in 2010 to treat pseudobulbar affect: involuntary emotional outbursts due to certain neurologic conditions or brain injury. I wondered whether to recommend Nuedexta for my elderly relative with worsening Alzheimers disease and daily spontaneous crying.

Pharmaceuticals 52

Pharmaceuticals 52

Judy Tsafrir, MD Blog

JULY 23, 2024

She shares insights on the limitations of conventional psychiatry, which often relies heavily on pharmaceuticals and overlooks the holistic integration of the spiritual, emotional, and physical dimensions of… The post Mending Mind and Spirit: The Path of Sacred Psychiatry first appeared on Judy Tsafrir, M.D.

Pharmaceuticals 52

Pharmaceuticals 52

Mad in America

FEBRUARY 28, 2024

Moore: And of course, it was an open door then for the pharmaceutical industry, wasn’t it, with their massive marketing dollars. And I think she’s right that medical psychiatry and the pharmaceutical companies needed a vision like that. But there are a lot of factors I think that influenced that.

Biopsychosocial model 142

Biopsychosocial model Aging and mental health Poverty and mental health Neurotransmitters and mental health 142

Psychiatric News

APRIL 21, 2025

adults admit that they are currently taking at least one pharmaceutical drug. Tuesday “ According to polling that was conducted by KFF , a whopping 61 percent of all U.S. “ Read here… [link]

Pharmaceuticals 40

Pharmaceuticals 40

Mad in America

JUNE 27, 2024

Given the current level of neuroscientific understanding of causality in the brain and nervous system, it seems pretty much inevitable that exposure to pharmaceutical psychotropics will produce adverse consequences. Even if the harms are not properly recognized or understood till decades later.

Early intervention 112

Early intervention Aging and mental health Pharmaceuticals Self-awareness 112

Mad in America

OCTOBER 14, 2023

Through the 1990s, I was dismayed that the influence of pharmaceutical marketing had seemed to suppress that idea, as polypharmacy and use of higher doses of drugs became part of accepted practice.

Hospitality 140

Hospitality Pharmaceuticals 140

Mad in America

FEBRUARY 22, 2025

Together, we have created a movement that rejects coercion, force, and pharmaceutical propaganda and embraces informed consent, individual choice, and alternative ways to deal with distress. A s we look back on the year and the decade, lets celebrate millions of people advocating for better outcomes in mental health care.

Self-awareness 128

Self-awareness Education Pharmaceuticals 128

Mad in America

JANUARY 24, 2024

Bolstered by the aggressive marketing of pharmaceuticals as precise tools targeting specific genetic markers, pharmacogenomics risks fuelling a cycle of dependency just as debilitating as the mental health conditions they aim to treat.

Genetics and mental health 122

Genetics and mental health Poverty and mental health Resilience and coping Healthcare 122

Mad in America

OCTOBER 31, 2023

Pharmaceutical companies, exerting their influence on academic psychiatry through lucrative honoraria and advisory board payments, have clearly played a role in how antidepressant risks have been presented. This notable gap has raised some suspicion that the necessary research has not merely been overlooked but deliberately avoided.

Cognitive Behavioral Therapy 122

Cognitive Behavioral Therapy Insurance Pharmaceuticals Community support 122

Psychiatric News

MARCH 18, 2025

Jnr is doing a wonderful job opening up the can of worms that is the pharmaceutical industry. We have finally turned the corner on the prescribing of these mind-altering drugs that for decades have been marketed as medicine.

Pharmaceuticals 40

Pharmaceuticals 40

Mad in America

NOVEMBER 5, 2024

We were also challenging the prevailing mental illness narrative espoused by NAMI, most psychiatrists, and the pharmaceutical industry. We struggled a lot because we were creating a new, unique, and empowered model network composed of voice hearers, family members, and clinicians. We found it was important we to look at our language.

Aging and mental health 114

Aging and mental health Hospitality Insurance Pharmaceuticals 114